Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics

Manoj Kumar Yadav, Indu Kumari, Bijender Singh, Krishna Kant Sharma, Santosh Kumar Tiwari, Manoj Kumar Yadav, Indu Kumari, Bijender Singh, Krishna Kant Sharma, Santosh Kumar Tiwari

Abstract

Probiotics have been considered as an economical and safe alternative for the treatment of a large number of chronic diseases and improvement of human health. They are known to modulate the host immunity and protect from several infectious and non-infectious diseases. The colonization, killing of pathogens and induction of host cells are few of the important probiotic attributes which affect several functions of the host. In addition, prebiotics and non-digestible food substances selectively promote the growth of probiotics and human health through nutrient enrichment, and modulation of gut microbiota and immune system. This review highlights the role of probiotics and prebiotics alone and in combination (synbiotics) in the modulation of immune system, treatment of infections, management of inflammatory bowel disease and cancer therapy. KEY POINTS: • Probiotics and their derivatives against several human diseases. • Prebiotics feed probiotics and induce several functions in the host. • Discovery of novel and biosafe products needs attention for human health.

Keywords: Chronic diseases; Human health; Prebiotics; Probiotics; Synbiotics.

Conflict of interest statement

The authors declare no competing interests.

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Figures

Fig. 1
Fig. 1
A schematic diagram showing the potential roles of prebiotics, probiotics and synbiotics in immune modulation, inhibition of HIV and coronaviruses, inflammatory bowel diseases and cancer cells. HIV, human immunodeficiency virus; CD4, cluster of differentiation 4; hsCRP, high-sensitivity C-reactive protein; B cells, t-lymphocyte cells; NK cells, natural killer cells; T cell, t-lymphocytes; IL-10, interleukin-10; IFN-g, interferon gamma. The pictures are taken from BioRender.com
Fig. 2
Fig. 2
A schematic diagram showing the modulation of host immune system by probiotics and their derivatives. Akt, protein kinase B; PKC, protein kinase C; TNF α, tumour necrosis factor α; NK cells, natural killer cells; IL-12, interleukin-12; Th1, type 1 t helper; IgA, immunoglobulin A

References

    1. Aachary AA, Prapulla SG. Xylooligosaccharides (XOS) as an emerging prebiotic: microbial synthesis, utilization, structural characterization, bioactive properties, and applications. Compr Rev Food Sci Food Saf. 2011;10:2–16. doi: 10.1111/j.1541-4337.2010.00135.x.
    1. Acuna L, Morero DR, Bellomio B. Development of wide-spectrum hybrid bacteriocins for food biopreservation. Food Bioprocess Technol. 2011;4:1029–1049. doi: 10.1007/s11947-010-0465-7.
    1. Ahlawat S, Asha, Sharma KK. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Res. 2020;286:198103. doi: 10.1016/j.virusres.2020.198103.
    1. Ahlawat S, Asha, Sharma KK. Gut-organ axis: a microbial outreach and networking. Lett Appl Microbiol. 2021;72:636–668. doi: 10.1111/lam.13333.
    1. Ahlawat S, Singh D, Yadav A, Singh AK, Virdi JS, Sharma KK. Proteomic analysis reveals the damaging role of low redox laccase from Yersinia enterocolitica strain 8081 in the midgut of Helicoverpa armigera. Biotechnol Lett. 2020;42:2189–2210. doi: 10.1007/s10529-020-02925-x.
    1. Ammor S, Tauveron G, Dufour E, Chevallier I. Antibacterial activity of lactic acid bacteria against spoilage and pathogenic bacteria isolated from the same meat small-scale facility: 1-Screening and characterization of the antibacterial compounds. Food Control. 2006;17:454–461. doi: 10.1016/j.foodcont.2005.02.006.
    1. Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43:246–252. doi: 10.1038/ng.764.
    1. Anukam KC, Osazuwa EO, Osadolor HB, Bruce AW, Reid G. Yogurt containing probiotic Lactobacillus rhamnosusGR-1 and L. reuteriRC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol. 2008;42:239–243. doi: 10.1097/MCG.0b013e31802c7465.
    1. Arnold C. The new danger of synthetic drugs. Lancet. 2013;382:15–16. doi: 10.1016/S0140-6736(13)61512-3.
    1. Barcenilla C, Ducic M, López M, Prieto M, Álvarez-Ordóñez A. Application of lactic acid bacteria for the biopreservation of meat products: a systematic review. Meat Sci. 2021;183:108661. doi: 10.1016/j.meatsci.2021.108661.
    1. Barefoot SF, Klaenhammer TR. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol. 1983;45:1808–1815. doi: 10.1128/aem.45.6.1808-1815.1983.
    1. Baricault L, Denariaz G, Houri JJ, Bouley C, Sapin C, Trugnan G. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis. 1995;16:245–252. doi: 10.1093/carcin/16.2.245.
    1. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121–141. doi: 10.1016/j.cell.2014.03.011.
    1. Berada N, Lemeland J, Laroche G, Thouveno P, Piaia M. Bifidobacterium from fermented milks: survival during gastric transit. J Dairy Sci. 1991;74:409–413. doi: 10.3168/jds.S0022-0302(91)78183-6.
    1. Bernardini S, Tiezzi A, Laghezza Masci V, Ovidi E. Natural products for human health: an historical overview of the drug discovery approaches. Nat Prod Res. 2018;32:1926–1950. doi: 10.1080/14786419.2017.1356838.
    1. Bhattacharya R, Gupta AM, Mitra S, Mandal S, Biswas SR. A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2. Virol. 2021;552:107–111. doi: 10.1016/j.virol.2020.10.002.
    1. Biedrzycka E, Bielecka M. Prebiotic effectiveness of fructans of different degrees of polymerization. Trends Food Sci Technol. 2004;15:170–175. doi: 10.1016/j.tifs.2003.09.014.
    1. Bielecka M, Biedrzycka E, Majkowska A. Selection of probiotics and prebiotics for synbiotics and confirmation of their in vivo effectiveness. Food Res Int. 2002;35:125–131. doi: 10.1016/S0963-9969(01)00173-9.
    1. Biragyn A, Ferrucci L. Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging. Lancet Oncol. 2018;19:e295–e304. doi: 10.1016/S1470-2045(18)30095-0.
    1. Bottcher MF, Nordin EK, Sandin A, Midtvedt T, Björkstén B. Microflora associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy. 2000;30:1591–1596. doi: 10.1046/j.1365-2222.2000.00982.x.
    1. Brandtzaeg P. Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest. 2010;39:303–355. doi: 10.3109/08820131003680369.
    1. Bruno FA, Lankaputhra WEV, Shah NP. Growth, viability and activity of Bifidobacterium spp. in skim milk containing prebiotics. J Food Sci. 2002;67:2740–2744. doi: 10.1111/j.1365-2621.2002.tb08807.x.
    1. Buck LM, Gilliland SE. Comparisons of freshly isolated strains of Lactobacillus acidophilus of human intestinal origin for ability to assimilate cholesterol during growth. J Dairy Sci. 1994;77:2925–2933. doi: 10.3168/jds.S0022-0302(94)77233-7.
    1. Chang YL, Rossetti M, Vlamakis H, Casero D, Sunga G, Harre N, Miller S, Humphries R, Stappenbeck T, Simpson KW, Sartor RB. A screen of Crohn’s disease–associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol. 2019;12:457–467. doi: 10.1038/s41385-018-0022-7.
    1. Chen X, Liu Y, Jin J, Liu H, Hao Y, Zhang H, Xie Y. YbfA regulates the sensitivity of Escherichia coli K12 to Plantaricin BM-1 via the BasS/BasRtwo-component regulatory system. Front Microbiol. 2021;12:659198. doi: 10.3389/fmicb.2021.659198.
    1. Christensen HR, Frøkiær H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol. 2002;168:171–178. doi: 10.4049/jimmunol.168.1.171.
    1. Cicero AF, Fogacci F, Bove M, Giovannini M, Borghi C. Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. Eur J Nutr. 2021;60:655–663. doi: 10.1007/s00394-020-02271-8.
    1. Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA. Nasal obstruction in patients with seasonal allergic rhinitis: relationships between allergic inflammation and nasal airflow. Int Arch Allergy Immunol. 2004;134:34–40. doi: 10.1159/000077531.
    1. Cleynen I, González JR, Figueroa C, Franke A, McGovern D, Bortlík M, Crusius BJ, Vecchi M, Artieda M, Szczypiorska M, Bethge J. Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBDchip European Project. Gut. 2013;62:1556–1565. doi: 10.1136/gutjnl-2012-304151.doi:10.1136/gutjnl-2011-300777.
    1. Coussement P. Pre-and synbiotics with inulin and oligofructose: promising developments in functional foods. Food Technol Eur. 1996;2:102–104.
    1. Cummings JH, Macfarlane GT, Englyst HN. Prebiotic digestion and fermentation. Am J Clin Nutr. 2001;73:415s–420s. doi: 10.1093/ajcn/73.2.415s.
    1. Dai C, Zhao DH, Jiang M. VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways. Int J Mol Med. 2012;29:202–208. doi: 10.3892/ijmm.2011.839.
    1. Dai M, Li Y, Xu L, Wu D, Zhou Q, Li P, Gu Q. A novel bacteriocin from Lactobacillus pentosus ZFM94 and its antibacterial mode of action. Front Nutr. 2021;8:710862. doi: 10.3389/fnut.2021.710862.
    1. Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Berenjian A, Ghasemi Y. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8:92. doi: 10.3390/foods8030092.
    1. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, Gozzi L, Lannone A, Lo Tartaro D, Mattioli M, Paolini A, Menozzi M, Milić J, Franceschi G, Fantini R, Tonelli R, Sita M, Sarti M, Trenti T, Brugioni L, Cicchetti L, Facchinetti F, Pietrangelo A, Clini E, Girardis M, Guaraldi G, Mussini C, Cossarizza A. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:3434. doi: 10.1038/s41467-020-17292-4.
    1. de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, Jostins L, Rice DL, Gutierrez-Achury J, Ji SG, Heap G, Nimmo ER, Edwards C, Henderson P, Mowat C, Sanderson J, Satsangi J, Simmons A, Wilson DC, Tremelling M, Hart A, Mathew CG, Newman WG, Parkes M, Lees CW, Uhlig H, Hawkey C, Prescott NJ, Ahmad T, Mansfield JC, Anderson CA, Barrett JC. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49:256–261. doi: 10.1038/ng.3760.
    1. Desai AR (2008) Strain identification, viability and probiotics properties of Lactobacillus casei. Ph.D. Thesis, School of Biomedical and Health Sciences. Victoria University, Werribee Campus Victoria, Australia
    1. d’Ettorre G, Ceccarelli G, Giustini N, Serafino S, Calantone N, De Girolamo G, Bianchi L, Bellelli V, Ascoli-Bartoli T, Marcellini S, Turriziani O, Brenchley JM, Vullo V. Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the “probio-HIV” clinical trial. PLoS ONE. 2015;10:e0137200. doi: 10.1371/journal.pone.0137200.
    1. Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004;3:1–21. doi: 10.1186/1475-2891-3-19.
    1. Eslamparast T, Zamani F, Hekmatdoost A, Sharafkhah M, Eghtesad S, Malekzadeh R, Poustchi H. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr. 2014;112:438–445. doi: 10.1017/S0007114514000919.
    1. Fathizadeh H, Pakdel F, Saffari M, Esmaeili DD, Momen-Heravi M, Dao S, Ganbarov K, Kafil HS. Bacteriocins: recent advances in application as an antimicrobial alternative. Curr Pharm Biotechnol. 2021 doi: 10.2174/1389201022666210907121254.
    1. Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:286–299. doi: 10.1097/00054725-200405000-00018.
    1. Floch MH. Probiotic therapy for ulcerative colitis. J Clin Gastroenterol. 2010;44:237–238. doi: 10.1097/MCG.0b013e3181cf837f.
    1. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–1125. doi: 10.1038/ng.717.
    1. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365–378. doi: 10.1111/j.1365-2672.1989.tb05105.x.
    1. Gibson GR, Beatty ER, Wang XIN, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterol. 1995;108:975–982. doi: 10.1016/0016-5085(95)90192-2.
    1. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491–502. doi: 10.1038/nrgastro.2017.75.
    1. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401–1412. doi: 10.1093/jn/125.6.1401.
    1. Gill HS. Stimulation of the immune system by lactic cultures. Int Dairy J. 1998;8:535–544. doi: 10.1016/S0958-6946(98)00074-0.
    1. Gill HS, Rutherfurd KJ, Cross ML. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol. 2001;21:264–271. doi: 10.1023/A:1010979225018.
    1. Gilliland SE, Speck ML. Deconjugation of bile acids by intestinal lactobacilli. Appl Environ Microbiol. 1977;33:15–18. doi: 10.1128/aem.33.1.15-18.1977.
    1. Gogineni VK, Morrow LE, Gregory PJ, Malesker MA. Probiotics: history and evolution. J Anc Dis Prev Rem. 2013;1:1–7. doi: 10.4172/2329-8731.1000107.
    1. Goldin BR, Gualtieri LJ, Moore RP. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr Cancer. 1996;25:197–204. doi: 10.1080/01635589609514442.
    1. Gori A, Rizzardini G, Van’t Land B, Amor KB, van Schaik J, Torti C, Quirino T, Tincati C, Bandera A, Knol J, Benlhassan-Chahour K, Trabattoni D, Bray D, Vriesema A, Welling G, Garssen J, Clerici M. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial. Mucosal Immunol. 2011;4:554–563. doi: 10.1038/mi.2011.15.
    1. Guarino MPL, Altomare A, Emerenziani S, Di Rosa C, Ribolsi M, Balestrieri P, Iovino P, Rocchi G, Cicala M. Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults. Nutrients. 2020;12:1037. doi: 10.3390/nu12041037.
    1. Gullon P, Moura P, Esteves MP, Girio FM, Domínguez H, Parajó JC. Assessment on the fermentability of xylooligosaccharides from rice husks by probiotic bacteria. J Agric Food Chem. 2008;56:7482–7487. doi: 10.1021/jf800715b.
    1. Harrison VC, Peat G, de Heese HV. Fetal growth in relation to histamine concentration in urine. J Obstet Gynaecol Br Commonw. 1974;81:686–690. doi: 10.1111/j.1471-0528.1974.tb00541.x.
    1. Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, Campieri M, Kamm MA, Knight SC, Stagg AJ. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut. 2004;53:1602–1609. doi: 10.1136/gut.2003.037325.
    1. Hartemink R, Rombouts FM. Gas formation from oligosaccharides by the intestinal microflora. In: Boehm G, editor. International Symposium on Pre and Probiotics. Wageningen: Wageningen Graduate School; 1997. pp. 57–66.
    1. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med. 1997;4:41–43. doi: 10.1111/j.1708-8305.1997.tb00772.x.
    1. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280. doi: 10.1016/j.cell.2020.02.052.
    1. Hughes DB, Hoover DG. Viability and enzymatic activity of bifidobacteria in milk. J Dairy Sci. 1995;78:268–276. doi: 10.3168/jds.S0022-0302(95)76634-6.
    1. Hummelen R, Changalucha J, Butamanya NL, Koyama TE, Cook A, Habbema JD, Reid G. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes. 2011;2:80–85. doi: 10.4161/gmic.2.2.15787.
    1. Ipar N, Aydogdu SD, Yildirim GK, Inal M, Gies I, Vandenplas Y, Dinleyici EC. Effects of synbiotic on anthropometry, lipid profile and oxidative stress in obese children. Benef Microbes. 2015;6:775–782. doi: 10.3920/BM2015.0011.
    1. Irvine SL, Hummelen R, Hekmat S. Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania. Nutr Res. 2011;31:875–881. doi: 10.1016/j.nutres.2011.10.005.
    1. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73:444s–450s. doi: 10.1093/ajcn/73.2.444s.
    1. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124. doi: 10.1038/nature11582.
    1. Kadowaki N. Dendritic cells: a conductor of T cell differentiation. Allergol Int. 2007;56:193–199. doi: 10.2332/allergolint.R-07-146.
    1. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992;32:141–144. doi: 10.1203/00006450-199208000-00002.
    1. Kanauchi O, Andoh A, AbuBakar S, Yamamoto N. Probiotics and paraprobiotics in viral infection: clinical application and effects on the innate and acquired immune systems. Curr Pharm Des. 2018;24:710–717. doi: 10.2174/1381612824666180116163411.
    1. Kawashima T, Hayashi K, Kosaka A, Kawashima M, Igarashi T, Tsutsui H, Tsuji NM, Nishimura I, Hayashi T, Obata A. Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses. Int Immunopharmacol. 2011;11:2017–2024. doi: 10.1016/j.intimp.2011.08.013.
    1. Khanna S, Bishnoi M, Kondepudi KK, Shukla G. Isolation, characterization and anti-inflammatory mechanism of probiotics in lipopolysaccharide-stimulated RAW 264.7 macrophages. World J Microbiol Biotechnol. 2020;36:74. doi: 10.1007/s11274-020-02852-z.
    1. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–317. doi: 10.1038/nature10209.
    1. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223–246.
    1. Kilara A, Shahani KM. Lactase activity of cultured and acidified dairy products. J Dairy Sci. 1976;59:2031–2035. doi: 10.3168/jds.S0022-0302(76)84484-0.
    1. Kim JU, Kim YH, Han KS, Oh SJ, Whang KY, Kim JN, Kim SH. Function of cell-bound and released exopolysaccharides produced by Lactobacillus rhamnosus ATCC 9595. J Microbiol Biotechnol. 2006;16:939–945.
    1. Kohmoto T, Fukui F, Takaku H, Machida Y, Arai M, Mitsuoka T. Effect of isomalto-oligosaccharides on human fecal flora. Bifidobacteria Microflora. 1988;7:61–69. doi: 10.12938/bifidus1982.7.2_61.
    1. Kolida S, Gibson GR. Synbiotics in health and disease. Ann Rev Food Sci Technol. 2011;2:373–393. doi: 10.1146/annurev-food-022510-133739.
    1. Korhonen J (2010) Antibiotic resistance of lactic acid bacteria. Dissertations, in Forestry and Natural Sciences, University of Eastern Finland
    1. Lambert J, Hull R. Upper gastrointestinal tract disease and probiotics. Asia Pac J Clin Nutr. 1996;5:31–35.
    1. Lankaputhra WEV, Shah NP, Britz ML. Evaluation of media for selected enumeration of Lactobacillus acidophilus and Bifidobacterium spp. Food Australia. 1996;48:113–118.
    1. Laroia S, Martin J. Bifidobacteria as possible dietary adjuncts in cultured dairy products-a review. Cult Dairy Prod J. 1990;25:18–22.
    1. Lee YK, Nomoto K, Salminen S, Gorbach SL. Handbook of probiotics. New York: John Wiley & Sons; 1999.
    1. Levy J. The effects of antibiotic use on gastrointestinal function. Am J Gastroenterol. 2000;95:S8–S10. doi: 10.1016/s0002-9270(99)00808-4.
    1. Lidbeck A, Allinger UG, Orrhage KM, Ottova L, Brismar B, Gustafsson J, Rafter JJ, Nord CE. Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microbial Ecol Health Dis. 1991;4:81–88. doi: 10.3109/08910609109140267.
    1. Linares DM, Gomez C, Renes E, Fresno JM, Tornadijo ME, Ross RP, Stanton C. Lactic acid bacteria and bifidobacteria with potential to design natural biofunctional health-promoting dairy foods. Front Microbiol. 2017;8:846. doi: 10.3389/fmicb.2017.00846.
    1. Liu G, Wang H, Griffiths WM, Li P. Heterologous extracellular production of enterocin P in Lactococcus lactis by a food-grade expression system. Eur Food Res Technol. 2011;233:123–129. doi: 10.1007/s00217-011-1494-9.
    1. Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Dayani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G, Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahedi H, Sood A, Sung JY, Malekzadeh R, Westra HJ, Yamazaki K, Yang SK, International Multiple Sclerosis Genetics Consortium. International IBD Genetics Consortium. Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–986. doi: 10.1038/ng.3359.
    1. Louis P, Flint HJ, Michel C. How to manipulate the microbiota: Prebiotics. Adv Exp Med Biol. 2016;902:119–142. doi: 10.1007/978-3-319-31248-4_9.
    1. Mackowiak PA. Recycling Metchnikoff: probiotics, the intestinal microbiome and the quest for long life. Front Public Health. 2013;1:52. doi: 10.3389/fpubh.2013.00052.
    1. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997;99:79–185. doi: 10.1016/S0091-6749(97)70093-9.
    1. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55:205–211. doi: 10.1136/gut.2005.073817.
    1. Mann GV, Spoerig A. Studies of a surfactant and cholesterolemia in the Masai. Am J Clin Nutr. 1974;27:464–469. doi: 10.1093/ajcn/27.5.464.
    1. Mantis NJ, Rol N, Corthésy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011;4:603–611. doi: 10.1038/mi.2011.41.
    1. Markowiak P, Slizewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9:1021. doi: 10.3390/nu9091021.
    1. Marlicz W, Skonieczna-Żydecka K, Dabos KJ, Łoniewski I, Koulaouzidis A. Emerging concepts in non-invasive monitoring of Crohn’s disease. Therap Adv Gastroenterol. 2018;18:11. doi: 10.1177/1756284818769076.
    1. Martinez-Villaluenga C, Gomez R. Characterization of bifidobacteria as starters in fermented milk containing raffinose family of oligosaccharides from lupin as prebiotic. Int Dairy J. 2007;17:116–122. doi: 10.1016/j.idairyj.2006.02.003.
    1. Masood MI, Qadir MI, Shirazi JH, Khan IU. Beneficial effects of lactic acid bacteria on human beings. Crit Rev Microbiol. 2011;37:91–98. doi: 10.3109/1040841X.2010.536522.
    1. McIntosh GH. Probiotics and colon cancer prevention. Asia Pac J Clin Nutr. 1996;5:48–52.
    1. McIntyre RE, Buczacki SJ, Arends MJ, Adams DJ. Mouse models of colorectal cancer as preclinical models. BioEssays. 2015;37:909–920. doi: 10.1002/bies.201500032.
    1. Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, Di W, Wang Z, Li Z, Gao H. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020;9:757–760. doi: 10.1080/22221751.2020.1746200.
    1. Merson MH, Morris GK, Sack DA, Wells JG, Feeley JC, Sack RB, Creech WB, Kapikian AZ, Gangarosa EJ. Travelers’ diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med. 1976;294:1299–1305. doi: 10.1056/NEJM197606102942401.
    1. Mishra C, Lambert J. Production of anti-microbial substances by probiotics. Asia Pac J Clin Nutr. 1996;5:20–24.
    1. Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A. 2005;102:2880–2885. doi: 10.1073/pnas.0500098102.
    1. Mombelli B, Gismondo MR. The use of probiotics in medical practice. Int J Antimicrob Agents. 2000;16:531–536. doi: 10.1016/s0924-8579(00)00322-8.
    1. Monachese M, Cunningham-Rundles S, Diaz MA, Guerrant R, Hummelen R, Kemperman R, Kerac M, Kort R, Merenstein D, Panigrahi P, Ramakrishna B, Safdar N, Shane A, Trois L, Reid G. Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report. Gut Microbes. 2011;2:198–207. doi: 10.4161/gmic.2.3.16106.
    1. Morimoto K, Takeshita T, Nanno M, Tokudome S, Nakayama K. Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. Prev Med. 2005;40:589–594. doi: 10.1016/j.ypmed.2004.07.019.
    1. Morotomi M. Properties of Lactobacillus casei Shirota strain as probiotics. Asia Pac J Clin Nutr. 1996;5:29–30.
    1. Murakami K, Habukawa C, Nobuta Y, Moriguchi N, Takemura T. The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial. Biopsychosoc Med. 2012;6:1–8. doi: 10.1186/1751-0759-6-16.
    1. Nagao F, Nakayama M, Muto T, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem. 2000;64:2706–2708. doi: 10.1271/bbb.64.2706.
    1. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N, Kitamura T, Kawabe K, Kotake T, Kuroda M, Naito S. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int. 2002;68:273–280. doi: 10.1159/000058450.
    1. Okazaki M, Fujikawa S, Mastumoto N. Effects of xylooligosaccharides on growth of Bifidobacteria. Bifidobactetria Microflora. 1990;9:77–86. doi: 10.12938/bifidus1982.9.2_77.
    1. Oksanen PJ, Salminen S, Saxelin M, Hämäläinen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, Nikkari S, Oksanen T, Pörsti I, Salminen E. Prevention of travellers’ diarrhoea by Lactobacillus GG. Ann Med. 1990;22:53–56. doi: 10.3109/07853899009147242.
    1. Olaimat AN, Aolymat I, Al-Holy M, Ayyash M, Ghoush MA, Al-Nabulsi AA, Osaili T, Apostolopoulos V, Liu SQ, Shah NP. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. NPJ Sci Food. 2020;4:1–7. doi: 10.1038/s41538-020-00078-9.
    1. Ongrádi J, Kövesdi V. Factors that may impact on immunosenescence: an appraisal. Immun Ageing. 2010;7:7. doi: 10.1186/1742-4933-7-7.
    1. Orrhage K, Brismar B, Nord CE. Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microbial Ecol Health Dis. 1994;7:17–25. doi: 10.3109/08910609409141570.
    1. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685–693. doi: 10.1136/gut.2003.025403.
    1. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek. 2002;82:279–289. doi: 10.1023/A:1020620607611.
    1. Panigrahi P, Parida S, Nanda NC, Satpathy R, Pradhan L, Chandel DS, Baccaglini L, Mohapatra A, Mohapatra SS, Misra PR, Chaudhry R, Chen HH, Johnson JA, Morris JG, Paneth N, Gewolb IH. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature. 2017;548:407–412. doi: 10.1038/nature23480.
    1. Papadimitriou K, Zoumpopoulou G, Foligné B, Alexandraki V, Kazou M, Pot B, Tsakalidou E. Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front Microbiol. 2015;6:58. doi: 10.3389/fmicb.2015.00058.
    1. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006;100:1171–1185. doi: 10.1111/j.1365-2672.2006.02963.x.
    1. Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S. A microbial signature for Crohn’s disease. Gut. 2017;66:813–822. doi: 10.1136/gutjnl-2016-313235.
    1. Pathmakanthan S, Walsh M, Bengmark S. Efficacy and tolerability treating acute distal ulcerative colitis with synbiotic enemas: a pilot trial (abstract) Geneva: United European Gastroenterology Week; 2002. p. 190.
    1. Perdigon G, Alvarez S, Nader ME, Macias DE, Roux ME, de Ruiz Holgado AP. The oral administration of lactic acid bacteria increase the mucosal intestinal immunity in response to enteropathogens. J Food Prot. 1990;53:404–410. doi: 10.4315/0362-028X-53.5.404.
    1. Perez-Conesa D, López G, Abellán P, Ros G. Bioavailability of calcium, magnesium and phosphorus in rats fed probiotic, prebiotic and synbiotic powder follow-up infant formulas and their effect on physiological and nutritional parameters. J Sci Food Agric. 2006;86:2327–2336. doi: 10.1002/jsfa.2618.
    1. Perrin S, Warchol M, Grill JP, Schneider F. Fermentations of fructo-oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi-synthetic medium. J Appl Microbiol. 2001;90:859–865. doi: 10.1046/j.1365-2672.2001.01317.x.
    1. Petrova P, Ivanov I, Tsigoriyna L, Valcheva N, Vasileva E, Parvanova-Mancheva T, Arsov A, Petrov K. Traditional Bulgarian dairy products: ethnic foods with health benefits. Microorganisms. 2021;9:480. doi: 10.3390/microorganisms9030480.
    1. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109:309–318. doi: 10.1179/2047773215Y.0000000030.
    1. Prosberg M, Bendtsen F, Vind I, Petersen AM, Gluud LL. The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis. Scand J Gastroenterol. 2016;51:407–1415. doi: 10.1080/00365521.2016.1216587.
    1. Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res. 1993;53:3914–3918.
    1. Roberfroid M, Gibson GR, Delzenne N. The biochemistry of oligofructose, a nondigestible fiber: an approach to calculate its caloric value. Nutr Rev. 1993;51:137–146. doi: 10.1111/j.1753-4887.1993.tb03090.x.
    1. Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr. 2000;71:1682S–1687S. doi: 10.1093/ajcn/71.6.1682S.
    1. Safavi M, Farajian S, Kelishadi R, Mirlohi M, Hashemipour M. The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial. Int J Food Sci Nutr. 2013;64:687–693. doi: 10.3109/09637486.2013.775224.
    1. Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M, Rezzonico E, Ngom-Bru C, Berger B, Philippe L, Ammon-Zuffrey C, Leone P, Chevrier G, St-Amand E, Marette A, Doré J, Tremblay A. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr. 2014;111:1507–1519. doi: 10.1017/S0007114513003875.
    1. Sarowska J, Choroszy-Krol I, Regulska-Ilow B, Frej-Mądrzak M, Jama-Kmiecik A. The therapeutic effect of probiotic bacteria on gastrointestinal diseases. Adv Clin Exp Med. 2013;22:759–766.
    1. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci. 1995;78:491–497. doi: 10.3168/jds.S0022-0302(95)76659-0.
    1. Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol. 2000;95:S19–S21. doi: 10.1016/S0002-9270(99)00812-6.
    1. Semjonovs SP, Marauska M, Linde R, Grube M, Zikmanis P, Bekers M. Development of Bifidobacterium lactis Bb12 on β-(2,6)-linked fructan-containing substrate. Eng Life Sci. 2004;4:433–437. doi: 10.1002/elsc.200420043.
    1. Shahani KM, Chandan RC. Nutritional and healthful aspects of cultured and culture-containing dairy foods. J Dairy Sci. 1979;62:1685–1694. doi: 10.3168/jds.S0022-0302(79)83481-5.
    1. Sharma M, Shukla G. Metabiotics: one step ahead of probiotics; an insight into mechanisms involved in anticancerous effect in colorectal cancer. Front Microbiol. 2016;7:1940. doi: 10.3389/fmicb.2016.01940.
    1. Sharma P, Kaur S, Chadha BS, Kaur R, Kaur M, Kaur S. Anticancer and antimicrobial potential of enterocin 12a from Enterococcus faecium. BMC Microbiol. 2021;21:39. doi: 10.1186/s12866-021-02086-5.
    1. Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr. 2001;20:149–156. doi: 10.1080/07315724.2001.10719027.
    1. Sheil B, Shanahan F, O’Mahony L. Probiotic effects on inflammatory bowel disease. J Nutr. 2007;137:819S–824S. doi: 10.1093/jn/137.3.819S.
    1. Sheoran P, Tiwari SK. Enterocin LD3 from Enterococcus hirae LD3 causing efflux of intracellular ions and UV absorbing materials in Gram-negative bacteria. J Appl Microbiol. 2019;126:1059–1069. doi: 10.1111/jam.14203.
    1. Sheoran P, Tiwari SK. Synergistically-acting enterocin LD3 and plantaricin LD4 against Gram-positive and Gram-negative pathogenic bacteria. Probiotics Antimicrob Proteins. 2020;13:542–554. doi: 10.1007/s12602-020-09708-w.
    1. Shim YH, Lee SJ, Lee JW. Antimicrobial activity of Lactobacillus strains against uropathogens. Pediatr Inter. 2016;58:1009–1013. doi: 10.1111/ped.12949.
    1. Shin HS, Lee JH, Pestka JJ, Ustunol Z. Growth and viability of commercial Bifidobacterium spp. in skim milk containing oligosaccharides and inulin. J Food Sci. 2000;65:884–887. doi: 10.1111/j.1365-2621.2000.tb13605.x.
    1. Sicherer SH, Muñoz-Furlong A, Sampson HA. Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol. 2004;114:159–165. doi: 10.1016/j.jaci.2004.04.018.
    1. Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, Kirkkola AL. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med. 1990;22:57–59. doi: 10.3109/07853899009147243.
    1. Silva DR, OrlandiSardi JC, Pitangui NS, MagriRoque S, Barbosa da Silva AC, Rosalen PL. Probiotics as an alternative antimicrobial therapy: current reality and future directions. J Funct Foods. 2020;73:104080. doi: 10.1016/j.jff.2020.104080.
    1. Singh K, Rao A. Probiotics: a potential immunomodulator in COVID-19 infection management. Nutr Res. 2021;87:1–12. doi: 10.1016/j.nutres.2020.12.014.
    1. Šmid A, Strniša L, Bajc K, Vujić-Podlipec D, Matijašić BB, Rogelj I. Randomized clinical trial: the effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacterium BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adults. J Funct Foods. 2016;24:549–557. doi: 10.1016/j.jff.2016.04.031.
    1. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105:16731–16736. doi: 10.1073/pnas.0804812105.
    1. Somashekaraiah R, Mottawea W, Gunduraj A, Joshi U, Hammami R, Sreenivasa MY. Probiotic and antifungal attributes of Levilactobacillus brevis MYSN105, isolated from an Indian traditional fermented food Pozha. Front Microbiol. 2021;12:696267. doi: 10.3389/fmicb.2021.696267.
    1. Starosila D, Rybalko S, Varbanetz L, Ivanskaya N, Sorokulova I. Anti-influenza activity of a Bacillus subtilis probiotic strain. Antimicrob Agents Chemother. 2017;61:e00539–e617. doi: 10.1128/AAC.00539-17.
    1. Strobel S, Strid J. Natural killer cells and aspects of intestinal immunity. In: Brostoff J, Challacombe SJ, editors. Food allergy and intolerance. London: Elsevier Science Limited; 2002. pp. 117–126.
    1. Sutas Y, Hurme M, Isolauri E. Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with LactobacillusGG-derived enzymes. Scand J Immunol. 1996;43:687–689. doi: 10.1046/j.1365-3083.1996.d01-258.x.
    1. Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, Scott KP, Holscher HD, Azad MB, Delzenne NM, Sanders ME. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17:687–701. doi: 10.1038/s41575-020-0344-2.
    1. Tajadadi-Ebrahimi M, Bahmani F, Shakeri H, Hadaegh H, Hijijafari M, Abedi F, Asemi Z. Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: a double-blind, randomized, controlled clinical trial. Ann Nutr Metab. 2014;65:34–41. doi: 10.1159/000365153.
    1. Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, Inatomi O, Bamba S, Andoh A, Sugimoto M. Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn’s disease. Digestion. 2016;93:59–65. doi: 10.1159/000441768.
    1. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept) Genes Nutr. 2011;6:261–274. doi: 10.1007/s12263-011-0218-x.
    1. Taylor SL, Hefle SL. Allergen control. Food. Sci Technol. 2005;59:40–43.
    1. Tharmaraj N, Shah NP. Antimicrobial effects of probiotics against selected pathogenic and spoilage bacteria in cheese-based dips. Int Food Res J. 2009;16:261–276.
    1. Tiwari SK, Dicks LMT, Popov IV, Karaseva A, Ermakov AM, Suvorov A, Tagg JR, Weeks R, Chikindas ML. Probiotics at war against viruses: what is missing from the picture? Front Microbiol. 2020;11:1877. doi: 10.3389/fmicb.2020.01877.
    1. Tojo M, Oikawa T, Morokawa Y, Yamashita N, Iwata S, Satoh Y, Hanada J, Tanaka R. The effects of Bifidobacterium breve administration on Campylobacter enteritis. Acta Aaediatr Jpn. 1987;29:160–167. doi: 10.1111/j.1442-200x.1987.tb00024.x.
    1. Trasande L, Shaffer RM, Sathyanarayana S. Food additives and child health. Pediatrics. 2018;142:e20181410. doi: 10.1542/peds.2018-1410.
    1. Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, Spencer JP. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr. 2011;93:62–72. doi: 10.3945/ajcn.110.000075.
    1. Uhlig HH, Muise AM. Clinical genomics in inflammatory bowel disease. Trends Genet. 2017;33:629–641. doi: 10.1016/j.tig.2017.06.008.
    1. Uhlig HH, Powrie F. Translating immunology into therapeutic concepts for inflammatory bowel disease. Ann Rev Immunol. 2018;36:755–781. doi: 10.1146/annurev-immunol-042617-053055.
    1. Van der Meer R, Bovee-Oudenhoven IMJ. Dietary modulation of intestinal bacterial infections. Int Dairy J. 1998;8:481–486. doi: 10.1016/S0958-6946(98)00072-7.
    1. Van der Meulen R, Avonts L, De Vuyst L. Short fractions of oligofructose are preferentially metabolized by Bifidobacteriumanimalis DN-173010. Appl Environ Microbiol. 2004;70:1923–1930. doi: 10.1128/AEM.70.4.1923-1930.2004.
    1. Van Laere KM, Hartemink R, Bosveld M, Schols HA, Voragen AG. Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria. J Agric Food Chem. 2000;48:1644–1652. doi: 10.1021/jf990519i.
    1. Vazquez MJ, Alonso JL, Domınguez H, Parajo JC. Xylooligosaccharides: manufacture and applications. Trends Food Sci Technol. 2000;11:387–393. doi: 10.1016/S0924-2244(01)00031-0.
    1. Vergin F. Anti- und Probiotika [Antibiotics and probiotics] Hippokrates. 1954;25:116–119.
    1. Wang W, Chen L, Zhou R, Wang X, Song L, Huang S, Wang G, Xia B. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol. 2014;52:398–406. doi: 10.1128/JCM.01500-13.
    1. Wang W, Xin H, Fang X, Dou H, Liu F, Huang D, Han S, Fei G, Zhu L, Zha S, Zhang H. Isomalto-oligosaccharides ameliorate visceral hyperalgesia with repair damage of ileal epithelial ultrastructure in rats. PLoS ONE. 2017;12:e0175276. doi: 10.1371/journal.pone.0175276.
    1. Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC, Chan HL. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol. 2013;12:256–262. doi: 10.1016/S1665-2681(19)31364-X.
    1. Yang SC, Chen JY, Shang HF, Cheng TY, Tsou SC, Chen JR. Effect of synbiotics on intestinal microflora and digestive enzyme activities in rats. World J Gastroenterol. 2005;11:7413. doi: 10.3748/wjg.v11.i47.7413.
    1. Yen CH, Tseng YH, Kuo YW, Lee MC, Chen HL. Long-term supplementation of isomalto-oligosaccharides improved colonic microflora profile, bowel function, and blood cholesterol levels in constipated elderly people–a placebo-controlled, diet-controlled trial. Nutrition. 2011;27:445–450. doi: 10.1016/j.nut.2010.05.012.
    1. Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol. 2014;29:52–59. doi: 10.1111/jgh.12322.
    1. Zeng H, Xue Y, Peng T, Shao W. Properties of xylanolytic enzyme system in bifidobacteria and their effects on the utilization of xylooligosaccharides. Food Chem. 2007;101:1172–1177. doi: 10.1016/j.foodchem.2006.03.019.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다